Cardiovascular risk in children and adolescents with end stage renal disease.

Maria Luiza do Val Fernanda Souza Menezes Henrique Tsuha Massaoka Valeska Tavares Scavarda Adriano Czapkowski Heitor Pons Leite Valdir Ambrósio Moises Sergio Aron Ajzen João Tomas de Abreu Carvalhaes José Osmar Medina de Abreu Pestana Paulo Cesar Koch Nogueira

Published in: Clinics (Sao Paulo, Brazil) (2019)

Children exhibited important cardiovascular involvement at the time of the renal transplantation. Both of the studied outcomes were independently associated with systolic blood pressure. For this reason, controlling blood pressure seems to be the main therapy to minimize cardiovascular involvement in children with ESRD.

Keyphrases

blood pressure
end stage renal disease
chronic kidney disease
peritoneal dialysis
hypertensive patients
young adults
heart rate
heart failure
left ventricular
stem cells
type diabetes
metabolic syndrome
adipose tissue
mesenchymal stem cells
insulin resistance
solid state
replacement therapy
smoking cessation